These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 8456808)

  • 1. Chemical cleavage method for the detection of RNA base changes: experience in the application to collagen mutations in osteogenesis imperfecta.
    Bateman JF; Lamande SR; Hannagan M; Moeller I; Dahl HH; Cole WG
    Am J Med Genet; 1993 Jan; 45(2):233-40. PubMed ID: 8456808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lethal perinatal osteogenesis imperfecta due to a type I collagen alpha 2(I) Gly to Arg substitution detected by chemical cleavage of an mRNA:cDNA sequence mismatch.
    Bateman JF; Moeller I; Hannagan M; Chan D; Cole WG
    Hum Mutat; 1992; 1(1):55-62. PubMed ID: 1284475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of point mutations in the collagen COL1A1 and COL1A2 genes causing lethal perinatal osteogenesis imperfecta.
    Lamande SR; Dahl HH; Cole WG; Bateman JF
    J Biol Chem; 1989 Sep; 264(27):15809-12. PubMed ID: 2777764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Four new cases of lethal osteogenesis imperfecta due to glycine substitutions in COL1A1 and genes. Mutations in brief no. 152. Online.
    Mottes M; Gomez Lira M; Zolezzi F; Valli M; Lisi V; Freising P
    Hum Mutat; 1998; 12(1):71-2. PubMed ID: 10627137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paternal mosaicism for a COL1A1 dominant mutation (alpha 1 Ser-415) causes recurrent osteogenesis imperfecta.
    Mottes M; Gomez Lira MM; Valli M; Scarano G; Lonardo F; Forlino A; Cetta G; Pignatti PF
    Hum Mutat; 1993; 2(3):196-204. PubMed ID: 8364588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thirty-three novel COL1A1 and COL1A2 mutations in patients with osteogenesis imperfecta types I-IV.
    Ward LM; Lalic L; Roughley PJ; Glorieux FH
    Hum Mutat; 2001 May; 17(5):434. PubMed ID: 11317364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a type I collagen alpha 2(I) glycine-586 to valine substitution in osteogenesis imperfecta type IV. Detection of the mutation and prenatal diagnosis by a chemical cleavage method.
    Bateman JF; Hannagan M; Chan D; Cole WG
    Biochem J; 1991 Jun; 276 ( Pt 3)(Pt 3):765-70. PubMed ID: 2064612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular heterogeneity in osteogenesis imperfecta type I.
    Willing MC; Pruchno CJ; Byers PH
    Am J Med Genet; 1993 Jan; 45(2):223-7. PubMed ID: 8456806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation analysis of coding sequences for type I procollagen in individuals with low bone density.
    Spotila LD; Colige A; Sereda L; Constantinou-Deltas CD; Whyte MP; Riggs BL; Shaker JL; Spector TD; Hume E; Olsen N
    J Bone Miner Res; 1994 Jun; 9(6):923-32. PubMed ID: 8079666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Canine COL1A2 mutation resulting in C-terminal truncation of pro-alpha2(I) and severe osteogenesis imperfecta.
    Campbell BG; Wootton JA; Macleod JN; Minor RR
    J Bone Miner Res; 2001 Jun; 16(6):1147-53. PubMed ID: 11393792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation analysis of COL1A1 and COL1A2 in patients diagnosed with osteogenesis imperfecta type I-IV.
    Pollitt R; McMahon R; Nunn J; Bamford R; Afifi A; Bishop N; Dalton A
    Hum Mutat; 2006 Jul; 27(7):716. PubMed ID: 16786509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in the COL1A2 gene of type I collagen that result in nonlethal forms of osteogenesis imperfecta.
    Wenstrup RJ; Lever LW; Phillips CL; Quarles LD
    Am J Med Genet; 1993 Jan; 45(2):228-32. PubMed ID: 8456807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amino acid sequence environment modulates the disruption by osteogenesis imperfecta glycine substitutions in collagen-like peptides.
    Yang W; Battineni ML; Brodsky B
    Biochemistry; 1997 Jun; 36(23):6930-5. PubMed ID: 9188687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (G586V) substitutions in the alpha 1 and alpha 2 chains of collagen I: effect of alpha-chain stoichiometry on the phenotype of osteogenesis imperfecta?
    Lund AM; Skovby F; Schwartz M
    Hum Mutat; 1997; 9(5):431-6. PubMed ID: 9143923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thermal stability and folding of the collagen triple helix and the effects of mutations in osteogenesis imperfecta on the triple helix of type I collagen.
    Bächinger HP; Morris NP; Davis JM
    Am J Med Genet; 1993 Jan; 45(2):152-62. PubMed ID: 8456797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A frameshift mutation results in a truncated nonfunctional carboxyl-terminal pro alpha 1(I) propeptide of type I collagen in osteogenesis imperfecta.
    Bateman JF; Lamande SR; Dahl HH; Chan D; Mascara T; Cole WG
    J Biol Chem; 1989 Jul; 264(19):10960-4. PubMed ID: 2500431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic and biochemical analyses of Israeli osteogenesis imperfecta patients.
    Ries-Levavi L; Ish-Shalom T; Frydman M; Lev D; Cohen S; Barkai G; Goldman B; Byers P; Friedman E
    Hum Mutat; 2004 Apr; 23(4):399-400. PubMed ID: 15024745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cysteine for glycine substitution at position 1017 in an alpha 1(I) chain of type I collagen in a patient with mild dominantly inherited osteogenesis imperfecta.
    Labhard ME; Wirtz MK; Pope FM; Nicholls AC; Hollister DW
    Mol Biol Med; 1988 Dec; 5(3):197-207. PubMed ID: 3244312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two new recurrent nucleotide mutations in the COL1A1 gene in four patients with osteogenesis imperfecta: about one-fifth are recurrent.
    Körkkö J; Kuivaniemi H; Paassilta P; Zhuang J; Tromp G; DePaepe A; Prockop DJ; Ala-Kokko L
    Hum Mutat; 1997; 9(2):148-56. PubMed ID: 9067755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.